Sundance Clinical Research is participating in a study evaluating an investigational vaccine given to
healthy pregnant women to see if it may protect their babies against Respiratory
Syncytial Virus, or RSV for short.
Are 18 to 49 years of age
Are a healthy pregnant woman expecting a healthy baby
Will be between 24 and 36 weeks pregnant on the day of your study injection
Meet additional requirements as determined by a screening process
For more information, submit your information using the link below. After you submit your information, a specialist will call you to talk about the study. There is no obligation to join — you can decide if the study is right for you.
You can also talk to a Sundance Patient Recruitment Specialist about this study by calling (314) 567-3377.